Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal The Wall Street Journal
Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...
View full coverage on Google Newshttps://ift.tt/eA8V8J
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean. 
No comments:
Post a Comment